SoundHealth has launched SONU, an AI-enabled wearable device for at-home treatment of nasal congestion due to allergic and non-allergic rhinitis in adults.

The over-the-counter device has received De Novo classification from the US Food and Drug Administration (FDA) and uses acoustic resonance therapy to alleviate symptoms.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

SONU operates by generating personalised acoustic vibrations that target nasal congestion, offering a safe alternative to pharmaceutical treatments.

The accompanying SONU app scans the user’s face to map their sinuses and determine the optimal frequencies for treatment.

Once the device is activated, the SONU band emits resonant sound waves to stimulate nasal nerves, leading to decreased swelling and improved mucus clearance.

Furthermore, SoundHealth has secured $7m in seed funding to boost the device’s marketing efforts and pursue regulatory approval for additional uses.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The investment round was led by Moai Capital and J4 Ventures, with contributions from TeleSoft Partners, TechU Ventures, Tau Ventures, Rhythm Venture Capital and Peter Moran.

Moran said: “SONU is using the latest medical science to provide a game-changing and liberating alternative treatment for nasal congestion. Investors are increasingly looking for high-efficacy solutions to many maladies without the side effects of pharmaceutical approaches.”

SoundHealth founder and CEO Dr Paramesh Gopi said: “We are delighted to announce the close of our seed-round investment — the proceeds of which will be used for product launch and advancing our pipeline of indications for the SONU device.

“Our groundbreaking technology provides the first FDA-authorised, non-pharmaceutical medical device treatment option for nasal congestion due to allergic and non-allergic rhinitis.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact